Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Wesseling

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Annals of the Rheumatic Diseases|February 26, 2013
The type I IFN signature as a biomarker of preclinical rheumatoid arthritisJoyce Lübbers, Mikael Brink, Lotte A van de Stadt, et al.
Annals of Surgery|November 25, 2003
A genetically retargeted adenoviral vector enhances viral transduction in esophageal carcinoma cell lines and primary cultured esophageal resection specimensChristianne J Buskens, Willem A Marsman, John G Wesseling, et al.
Biochemical and Biophysical Research Communications|July 24, 2002
Adenoviral overexpression of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in miceHendrik N van der Vliet, Frank G Schaap, Johannes H M Levels, et al.
Biochemical and Biophysical Research Communications|May 14, 1993
Inhibin subunits, follistatin and activin receptors in the human teratocarcinoma cell line Tera-2F H de Jong, J P de Winter, J G Wesseling, et al.
Cancer Gene Therapy|January 10, 2002
Midkine and cyclooxygenase-2 promoters are promising for adenoviral vector gene delivery of pancreatic carcinomaJ G Wesseling, M Yamamoto, Y Adachi, et al.
Cancer Gene Therapy|February 7, 2004
Gene therapy for esophageal carcinoma: the use of an explant model to test adenoviral vectors ex vivoWillem A Marsman, Christianne J Buskens, John G Wesseling, et al.
Annals of the Rheumatic Diseases|May 29, 2015
B cell signature contributes to the prediction of RA development in patients with arthralgiaJoyce Lübbers, Saskia Vosslamber, Lotte A van de Stadt, et al.
Cancer Gene Therapy|January 31, 2009
Fiber-chimeric adenoviruses expressing fibers from serotype 16 and 50 improve gene transfer to human pancreatic adenocarcinomaK F D Kuhlmann, M A van Geer, C T Bakker, et al.
International Journal of Oncology|December 4, 2009
A fiber modified adenovirus vector that targets to the EphrinA2 receptor reveals enhanced gene transfer to ex vivo pancreatic cancerMichael A Van Geer, Daniel Brevoord, Koert F D Kuhlmann, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2004
Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patientsK F D Kuhlmann, S M M de Castro, J G Wesseling, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Annals of the Rheumatic Diseases|February 26, 2013
The type I IFN signature as a biomarker of preclinical rheumatoid arthritisJoyce Lübbers, Mikael Brink, Lotte A van de Stadt, et al.
Annals of Surgery|November 25, 2003
A genetically retargeted adenoviral vector enhances viral transduction in esophageal carcinoma cell lines and primary cultured esophageal resection specimensChristianne J Buskens, Willem A Marsman, John G Wesseling, et al.
Biochemical and Biophysical Research Communications|July 24, 2002
Adenoviral overexpression of apolipoprotein A-V reduces serum levels of triglycerides and cholesterol in miceHendrik N van der Vliet, Frank G Schaap, Johannes H M Levels, et al.
Biochemical and Biophysical Research Communications|May 14, 1993
Inhibin subunits, follistatin and activin receptors in the human teratocarcinoma cell line Tera-2F H de Jong, J P de Winter, J G Wesseling, et al.
Cancer Gene Therapy|January 10, 2002
Midkine and cyclooxygenase-2 promoters are promising for adenoviral vector gene delivery of pancreatic carcinomaJ G Wesseling, M Yamamoto, Y Adachi, et al.
Cancer Gene Therapy|February 7, 2004
Gene therapy for esophageal carcinoma: the use of an explant model to test adenoviral vectors ex vivoWillem A Marsman, Christianne J Buskens, John G Wesseling, et al.
Annals of the Rheumatic Diseases|May 29, 2015
B cell signature contributes to the prediction of RA development in patients with arthralgiaJoyce Lübbers, Saskia Vosslamber, Lotte A van de Stadt, et al.
Cancer Gene Therapy|January 31, 2009
Fiber-chimeric adenoviruses expressing fibers from serotype 16 and 50 improve gene transfer to human pancreatic adenocarcinomaK F D Kuhlmann, M A van Geer, C T Bakker, et al.
International Journal of Oncology|December 4, 2009
A fiber modified adenovirus vector that targets to the EphrinA2 receptor reveals enhanced gene transfer to ex vivo pancreatic cancerMichael A Van Geer, Daniel Brevoord, Koert F D Kuhlmann, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2004
Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patientsK F D Kuhlmann, S M M de Castro, J G Wesseling, et al.
Pageof 6